Table 3: Clinical and
laboratorial data according to age group in adolescents and adults with severe
obesity.
Variables |
Adolescents (n = 60) % (n) |
Adults (n = 68) % (n) |
p-value |
Hyperglycemia |
35 (21) |
44.1 (30) |
0.293 |
Insulinresistance |
53.3 (32) |
76.5 (52) |
0.008* |
Hypercholesterolemia |
88.3 (53) |
52.9 (36) |
0.000* |
High LDL-c |
73.3 (44) |
42.6 (29) |
0.000* |
Reduced HDL-c |
43.3 (26) |
20.6 (14) |
0.006* |
Hypertriglyceridemia |
68.3 (41) |
36.8 (25) |
0.000* |
High CRP |
93.3 (56) |
94.1 (64) |
0.539 |
Hepatic Steatosis |
80 (48) |
79.4(54) |
0.934 |
High bloodpressure |
65 (39) |
60.3 (41) |
0.583 |
Metabolicsyndrome |
60 (36) |
63.2 (43) |
0.707 |
*Values with
statistical significance (p ≤ 0.005)